Stocks opened lower and bounced around the breakeven line before optimism about U.S.-China relations and earnings from banks both big and small took hold among buyers during the last session of the trading week. Trade war and credit concerns ebbed, and a risk-on mood prevailed as a volatile five days ended on positive notes.
In an interview with Fox Business, President Donald Trump acknowledged that a maximum 157% tariffs on exports to the U.S. from China can't go on for long. "It's not sustainable, but that's what the number is," Trump said. "It's probably not, you know, it could stand. But they forced me to do that."
The president also affirmed that he and Chinese President Xi Jinping will meet in South Korea "in a couple of weeks" and expressed optimism about their upcoming talks. "I think we're going to do fine with China. I get along great with him. He's a very strong leader, a very, you know, amazing man," the president said of his counterpart. "But we have to have a fair deal. It's gotta be fair."
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The Cboe Volatility Index (VIX) crested early at 28.99, up from 25.31 on Thursday and as high as it's been since reaching 29.66 on April 24, and fell back to 21.46. The VIX has risen from 16.43 on October 9. A "normal" range for what's widely recognized as the market's "fear index" is between 12 and 20.
At Friday's closing bell, the blue chip Dow Jones Industrial Average was up 0.5% to 46,190 and climbed 1.6% for the week. The broad-based S&P 500 had added 0.5% at 6,664 to extend its five-day gain to 1.7%. The tech-heavy Nasdaq Composite was higher by 0.5% to 22,679 and posted a 2.1% weekly rise.
Is the system full of cockroaches?
Zions Bancorp (ZION, +5.8%) rebounded on Friday after a $50 million charge-off in its third-quarter earnings report caused it to fall 13% and lose about $1 billion in market cap on Thursday.
Regional banks recovered too, though small-cap stocks, as represented by the Russell 2000 Index, saw a 0.6% decline but still finished up 2.4% for the week.
JPMorgan Chase (JPM, -0.3%) CEO Jamie Dimon referred to a couple of regional banks as "cockroaches" during his comments to analysts following his bank's third-quarter earnings report. The comment went viral, and, as Louis Navellier of Navellier & Associates observes, "Several regional banks posted larger-than-expected loan-loss reserves, the highest in three years."
Higher provisions for credit losses "spooked the market and reignited fears of more 'cockroaches' lurking in the banking sector."
On Friday, Baird analyst David George raised his rating on ZION to Outperform (or Buy) from Neutral (or Hold) and reiterated his $65 12-month target price. George said Thursday's sell-off was "overdone," citing "disciplined" loan growth.
"We feel like the panic selling provides a great opportunity to buy ZION shares here," George concluded. "The fraud-related nature of this announcement leads us to believe this is a unique borrower rather than anything systemic."
The membership is spending
American Express (AXP, +7.3%) was the best-performing Dow Jones stock on Friday after management reported earnings of $4.14 per share (+18.6% year over year) on company-record revenue of $18.4 billion (+10.7% YoY). Wall Street expected EPS of $4.00 on revenue of $18 billion.
Management cited higher spending among its affluent customers, as credit card member spend growth accelerated to 9%. Based on its strong year-to-date performance, management raised its full-year guidance to EPS of $15.20 to $15.50 on revenue growth of 9% to 10%.
"The successful launch of our updated U.S. Consumer and Business Platinum Cards reinforces our leadership in the premium space," said CEO Stephen Squeri.
Praxis!
Praxis Precision Medicines (PRAX, +16.8%) enjoyed another big day on the price-action front, adding $500 million more to a market cap that's climbed from just north of $1 billion on Wednesday to near $4 billion.
On Tuesday, management reported positive results for its experimental drug to treat "essential tremor," a nervous system condition that causes involuntary shaking in the hands and arms with no specific treatment yet.
That marked a dramatic counterpoint to a February recommendation by an independent data monitoring committee overseeing the study to stop it "for futility, due to the results being unlikely to meet the primary efficacy endpoint under the parameters set by the statistical model."
Related content
- Five Stocks to Buy for a Trump Presidency
- Kiplinger's Economic Calendar and Analysis for This Week (October 20-24)
- Earnings Calendar and Analysis for This Week (October 20-24)
-
Kiplinger News Quiz, Oct 17 — Longest Government Shutdown?Quiz We covered stories about the shutdown, Medicare and vehicle recalls this week, but why? Test yourself on the latest financial and business news.
-
How Fast Does Your Internet Really Need to Be?From solo streamers to bustling smart homes, here’s how to match your internet speed to your lifestyle and know when it’s time to upgrade.
-
I Bought Palantir When It Was Trading at $8. Now It's $180 and I've Made $1 Million. What Do I Do?What do you do with all that appreciated Palantir stock? We asked a financial expert for advice.
-
Treat Home Equity Like Other Investments in Your Retirement Plan: Look at Its Track RecordHomeowners who are considering using home equity in their retirement plan can analyze it like they do their other investments. Here's how.
-
Why Does It Take Insurers So Darn Long to Pay Claims? An Insurance Expert ExplainsThe process of verification, investigation and cost assessment after a loss is complex and goes beyond simply cutting a check.
-
Two Reasons to Consider Deferred Compensation in the Wake of the OBBB, From a Financial PlannerDeferred compensation plans let you potentially lower your current taxes and help to keep you out of a higher tax bracket. It's important to consider the risks.
-
Dow Sinks 301 Points on Trade War Talk: Stock Market TodayThe contentious relationship between the world's two biggest economies continues to drive global financial markets.
-
The Best Gold Mutual Funds to Buy Right Now — And When to Choose An ETF InsteadGold mutual funds offer investors exposure to the yellow precious metal, which has been red-hot this year. But a caveat is required.
-
Financial Fact vs Fiction: The Truth About Social Security Entitlement (and Reverse Mortgages' Bad Rap)Despite the 'entitlement' moniker, Social Security and Medicare are both benefits that workers earn. And reverse mortgages can be a strategic tool for certain people. Plus, we're setting the record straight on three other myths.
-
The End of 2%? An Investment Adviser's Case for Why the Fed Should Raise Its Inflation TargetYes, inflation can be tough on those living on fixed incomes, but protecting us from it too strictly could do our overall economy more harm than good.
